Simone Mocellin
#145,263
Most Influential Person Now
Researcher
Simone Mocellin's AcademicInfluence.com Rankings
Simone Mocellinlaw Degrees
Law
#2595
World Rank
#3231
Historical Rank
Common Law
#117
World Rank
#126
Historical Rank
International Law
#623
World Rank
#775
Historical Rank
Simone Mocellinengineering Degrees
Engineering
#5637
World Rank
#6900
Historical Rank
Biomedical Engineering
#447
World Rank
#456
Historical Rank
Download Badge
Law Engineering
Simone Mocellin's Degrees
- PhD Biomedical Engineering Polytechnic University of Milan
- Masters Biomedical Engineering Polytechnic University of Milan
- Bachelors Biomedical Engineering Polytechnic University of Milan
Why Is Simone Mocellin Influential?
(Suggest an Edit or Addition)Simone Mocellin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The dual role of IL-10. (2003) (464)
- Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. (2012) (426)
- Interleukin‐10 and the immune response against cancer: a counterpoint (2005) (411)
- Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. (2010) (393)
- Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities (2007) (383)
- The Ratio Between Metastatic and Examined Lymph Nodes (N Ratio) Is an Independent Prognostic Factor in Gastric Cancer Regardless of the Type of Lymphadenectomy: Results From an Italian Multicentric Study in 1853 Patients (2007) (338)
- Tumor necrosis factor, cancer and anticancer therapy. (2005) (311)
- IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1 (2009) (301)
- Postoperative adjuvant chemotherapy in rectal cancer operated for cure. (2012) (287)
- Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients (2008) (276)
- Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. (2002) (265)
- The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. (2004) (252)
- Cytokines and Immune Response in the Tumor Microenvironment (2001) (244)
- Part I: Vaccines for solid tumours. (2004) (212)
- Circulating tumor cells: the 'leukemic phase' of solid cancers. (2006) (210)
- The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis (2006) (208)
- Interferon alpha for the adjuvant treatment of cutaneous melanoma. (2013) (191)
- Quantitative real-time PCR: a powerful ally in cancer research. (2003) (183)
- Gastrointestinal stromal tumors: From a surgical to a molecular approach (2003) (163)
- Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. (2015) (162)
- Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? (2007) (156)
- Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis (2013) (149)
- Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis (2017) (146)
- Genetic variation and gastric cancer risk: a field synopsis and meta-analysis (2015) (141)
- Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma (2003) (140)
- Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI) (2009) (137)
- Effect of BRCA germline mutations on breast cancer prognosis (2016) (136)
- Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. (2012) (134)
- A gene expression signature associated with survival in metastatic melanoma (2006) (122)
- The prognostic value of serum S100B in patients with cutaneous melanoma: A meta‐analysis (2008) (122)
- Complementary techniques: validation of gene expression data by quantitative real time PCR. (2007) (121)
- Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis (2004) (116)
- The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients (2003) (116)
- EUS for the staging of gastric cancer: a meta-analysis. (2011) (114)
- Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. (2019) (114)
- Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). (2013) (110)
- The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. (2008) (110)
- TNF and cancer: the two sides of the coin. (2008) (105)
- Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade (2018) (104)
- Telomerase and the search for the end of cancer. (2013) (103)
- The dual role of tumor necrosis factor (TNF) in cancer biology. (2010) (100)
- IL-10 stimulatory effects on human NK cells explored by gene profile analysis (2004) (99)
- Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression (2015) (97)
- The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study (2012) (96)
- Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. (2007) (95)
- Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy. (2017) (93)
- Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination (2001) (93)
- RNA interference: learning gene knock-down from cell physiology (2004) (90)
- Electrochemotherapy for disseminated superficial metastases from malignant melanoma (2012) (88)
- Extent of lymph node dissection for adenocarcinoma of the stomach. (2015) (87)
- Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors. (2016) (87)
- Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis (2002) (82)
- Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis (2012) (82)
- Suppressive Influences in the Immune Response to Cancer (2009) (79)
- Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. (2009) (75)
- Gene Expression Profile of Primary Gastric Cancer: Towards the Prediction of Lymph Node Status (2007) (73)
- Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node (2008) (71)
- Soft tissue limb sarcomas (1999) (70)
- Cutaneous melanoma in situ: translational evidence from a large population-based study. (2011) (68)
- Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. (2006) (68)
- Tumor necrosis factor (TNF) biology and cell death. (2008) (66)
- CTLA-4 blockade and the renaissance of cancer immunotherapy. (2013) (65)
- DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. (2009) (63)
- Hyperthermic Isolated Limb Perfusion With Low-Dose Tumor Necrosis Factor-α and Melphalan for Bulky In-Transit Melanoma Metastases (2004) (62)
- Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness (2001) (61)
- The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). (2006) (61)
- Interventions for melanoma in situ, including lentigo maligna. (2014) (60)
- Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET). (2013) (60)
- Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies (2018) (60)
- Vitamin D receptor polymorphisms and the risk of cutaneous melanoma (2008) (56)
- Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. (2014) (56)
- Early (sentinel lymph node biopsy‐guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases (2010) (55)
- Adjuvant immunotherapy for solid tumors: from promise to clinical application (2002) (54)
- Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival (2009) (54)
- Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading (2001) (53)
- Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high‐risk cutaneous melanoma (2004) (53)
- Role of resection margins in patients treated with breast conservation surgery (2008) (52)
- Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis (2017) (51)
- Systemic treatments for metastatic cutaneous melanoma (2012) (50)
- Electrochemotherapy Treatment of Locally Advanced and Metastatic Soft Tissue Sarcomas: Results of a Non-Comparative Phase II Study (2014) (50)
- Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis. (2017) (49)
- Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. (2003) (49)
- Oncomirs: from tumor biology to molecularly targeted anticancer strategies. (2009) (48)
- Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. (2015) (47)
- Nitric oxide: cancer target or anticancer agent? (2009) (47)
- Peptide-based anticancer vaccines: recent advances and future perspectives. (2009) (47)
- Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis (2017) (47)
- Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study (2017) (46)
- Isolated limb perfusion in locally advanced cutaneous melanoma. (2002) (46)
- Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma. (2015) (46)
- Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma. (2014) (45)
- The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanoma. (2010) (43)
- Early detection of melanoma: an educational campaign in Padova, Italy (2000) (43)
- Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. (2003) (42)
- The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis. (2014) (42)
- DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer. (2005) (42)
- Hyperthermic Isolated Perfusion With Low-Dose Tumor Necrosis Factor α and Doxorubicin for the Treatment of Limb-Threatening Soft Tissue Sarcomas (2005) (41)
- Correspondence 1: Cancer vaccines: pessimism in check (2004) (41)
- Cancer vaccine development: on the way to break immune tolerance to malignant cells. (2004) (41)
- Basal cell carcinoma: 10-year experience with electrochemotherapy (2017) (41)
- Sentinel node biopsy performance after neoadjuvant chemotherapy in locally advanced breast cancer: A systematic review and meta‐analysis (2016) (41)
- Second-line systemic therapy for metastatic colorectal cancer. (2017) (40)
- Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA‐Cw*0702‐associated epitope MAGE‐A12:170–178 (2003) (39)
- Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. (2001) (39)
- N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma (2007) (39)
- Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. (2005) (39)
- Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. (2016) (38)
- Vitamin D and cancer: deciphering the truth. (2011) (37)
- An integrative framework identifies alternative splicing events in colorectal cancer development (2014) (37)
- Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. (2003) (36)
- Part II: Vaccines for haematological malignant disorders. (2004) (36)
- Identification of Immune Dominant Cytomegalovirus Epitopes Using Quantitative Real-Time Polymerase Chain Reactions to Measure Interferon-&ggr; Production by Peptide-Stimulated Peripheral Blood Mononuclear Cells (2002) (35)
- Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines (2008) (34)
- Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide (2017) (34)
- Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma (2015) (34)
- Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. (2015) (33)
- Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes (2013) (32)
- Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases (2010) (32)
- Sentinel Node Status Prediction by Four Statistical Models: Results From a Large Bi-Institutional Series (n = 1132) (2009) (32)
- The Impact of Surgery on Survival of Patients With Cutaneous Melanoma: Revisiting the Role of Primary Tumor Excision Margins (2011) (32)
- Principles of gene microarray data analysis. (2007) (31)
- Colorectal cancer vaccines: principles, results, and perspectives. (2004) (31)
- Prognostic value of subclassification of T2 tumours in patients with gastric cancer (2009) (30)
- Molecular oncology in the post-genomic era: the challenge of proteomics. (2004) (30)
- Sentinel node biopsy and ultrasound scanning in cutaneous melanoma: clinical and technical considerations. (2000) (28)
- Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (n = 2,155): focus on the T category. (2011) (28)
- Gold Nanoparticle Aggregates Functionalized with Cyclic RGD Peptides for Targeting and Imaging of Colorectal Cancer Cells (2019) (27)
- Cancer resistance to type II topoisomerase inhibitors. (2012) (27)
- New paradigm for stage III melanoma: from surgery to adjuvant treatment (2019) (27)
- Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma. (2003) (26)
- Coinhibitory molecules in cancer biology and therapy. (2013) (25)
- RNA interference: ready to silence cancer? (2005) (24)
- Increased TIA‐1 gene expression in the tumor microenvironment after locoregional administration of tumor necrosis factor‐α to patients with soft tissue limb sarcoma (2003) (24)
- Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. (2011) (24)
- MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts. (2006) (24)
- Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. (2011) (23)
- Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR) (2003) (23)
- DNA Array-Based Gene Profiling in Tumor Immunology (2004) (22)
- Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. (2005) (21)
- Induction of Endothelial Nitric Oxide Synthase Expression by Melanoma Sensitizes Endothelial Cells to Tumor Necrosis Factor-Driven Cytotoxicity (2004) (21)
- Support Vector Machine Learning Model for the Prediction of Sentinel Node Status in Patients With Cutaneous Melanoma (2006) (20)
- Targeted therapy for colorectal cancer: mapping the way. (2005) (20)
- External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study. (2015) (20)
- Histopathological characteristics of subsequent melanomas in patients with multiple primary melanomas (2014) (18)
- Stop-flow technique for loco-regional delivery of antiblastic agents: literature review and personal experience. (2002) (18)
- Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology (2010) (18)
- Microarray technology and cancer gene profiling (2007) (18)
- Circulating tumor cells in solid cancer: Tumor marker of clinical relevance? (2008) (17)
- Spindle Cell/Sclerosing Rhabdomyosarcoma (2020) (17)
- Quantitative real-time PCR in cancer research. (2003) (17)
- Treatment options for liver metastases from colorectal cancer. (2003) (17)
- Risk-reducing medications for primary breast cancer: a network meta-analysis. (2019) (17)
- Towards the development of tumor necrosis factor (TNF) sensitizers: making TNF work against cancer. (2007) (17)
- TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial (2008) (16)
- The Effect of Lymph Node Dissection on the Survival of Patients With Operable Gastric Carcinoma. (2016) (16)
- Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. (2010) (16)
- The matrix protein pp65341‐350: a peptide that induces ex vivo stimulation and in vitro expansion of CMV‐specific CD8+ T cells in subjects bearing either HLA‐A*2402 or A*0101 allele (2003) (16)
- TNF&agr;-Based Isolated Perfusion for Limb-Threatening Soft Tissue Sarcomas: State of the Art and Future Trends (2003) (16)
- Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases. (2019) (16)
- Erratum: Part 1: Vaccines for solid tumours (Lancet Oncology (2004) vol. 5 (681-689)) (2005) (15)
- Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy. (2009) (15)
- Laser Scanning Cytometry Evaluation of MART-1, gp100, and HLA-A2 Expression in Melanoma Metastases (2001) (15)
- Recent advances in conventional and molecular prognostic factors for gastric carcinoma. (2008) (15)
- Separate cavity margins excision as a complement to conservative breast cancer surgery. (2010) (14)
- BRAF Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors (2018) (14)
- The melanoma molecular map project. (2008) (14)
- Cancer vaccines: the challenge of developing an ideal tumor killing system. (2005) (14)
- Strategies to enhance the anticancer potential of TNF. (2008) (14)
- The Usefulness of Quantitative Real-Time PCR in Immunogenetics (12)
- Actual False-Negative Rate Prompts the Routine Use of Ultrasound Scan Before and After Sentinel Node Biopsy in Melanoma (2008) (11)
- Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis (2018) (11)
- Myoepithelioma of the soft tissue: A systematic review of clinical reports. (2019) (11)
- Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis (2018) (10)
- Human miRNome profiling in colorectal cancer and liver metastasis development (2014) (10)
- Germline variation of circadian pathway genes and prognosis of gastric cancer patients (2017) (9)
- Doxorubicin Activity Is Enhanced by Hyperthermia in a Model of Ex Vivo Vascular Perfusion of Human Colon Carcinoma (2003) (9)
- Management of melanoma patients during COVID‐19 pandemic in an Italian skin unit (2021) (9)
- Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes. (2017) (9)
- Understanding the good and poor cell targeting activity of gold nanostructures functionalized with molecular units for the epidermal growth factor receptor (2019) (9)
- Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune Modulation (2007) (9)
- Targeting death receptors to fight cancer: from biological rational to clinical implementation. (2010) (9)
- Pelvic lymph node status prediction in melanoma patients with inguinal lymph node metastasis (2014) (9)
- Germline polymorphisms of circadian genes and gastric cancer predisposition (2020) (8)
- A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients (2020) (8)
- True versus Mild Hyperthermia during Isolated Hepatic Perfusion: Effects on Melphalan Pharmacokinetics and Liver Function (2004) (8)
- E2F1 germline copy number variations and melanoma susceptibility (2019) (8)
- Overall survival in BRCA-associated ovarian cancer: case-control study of an Italian series. (2010) (8)
- Circumventing melanoma chemoresistance by targeting DNA repair. (2012) (8)
- Differences in telomere length between sporadic and familial cutaneous melanoma (2016) (7)
- Correlation Between Melphalan Pharmacokinetics and Hepatic Toxicity Following Hyperthermic Isolated Liver Perfusion for Unresectable Metastatic Disease (2007) (7)
- Hyperthermic Isolated Perfusion with Low-Dose TNFα and Doxorubicin in Patients with Locally Advanced Soft Tissue Limb Sarcomas (2004) (7)
- Systemic treatments for metastatic cutaneous melanoma: (Protocol) (2014) (7)
- Analysis of clinical features of ovarian cancer (OC) and breast cancer (BC) among BRCA-mutated (BRCA+) and sporadic (NH) double tumors. (2012) (7)
- miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis (2019) (7)
- CIC-Rearranged Sarcoma (2020) (7)
- TNFalpha-based isolated perfusion for limb-threatening soft tissue sarcomas: state of the art and future trends. (2003) (7)
- Soft Tissue Tumors: A Practical and Comprehensive Guide to Sarcomas and Benign Neoplasms (2020) (6)
- Dermatofibroma (2020) (6)
- The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI) (2021) (6)
- Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node (2008) (6)
- Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors. (2020) (6)
- Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143) (2021) (6)
- Genetic variation and gastric cancer risk : a fi eld synopsis and meta-analysis (2015) (6)
- Priming anticancer active specific immunotherapy with dendritic cells. (2005) (6)
- Prototyping a precision oncology 3.0 rapid learning platform (2018) (5)
- Search for Melanoma Markers in Plasma and Serum Samples (2005) (5)
- Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience (2020) (5)
- Phase I–II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities (2003) (5)
- Low-Grade Endometrial Stromal Sarcoma (2020) (5)
- Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs (2022) (5)
- Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. (2015) (5)
- Tumor Vasculature: The Achilles` Heel of Cancer ? (2006) (5)
- New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside. (2006) (4)
- The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis (2018) (4)
- Macrophage-Mediated Melanoma Reduction after HP-NAP Treatment in a Zebrafish Xenograft Model (2022) (4)
- [Electrochemotherapy: mechanism of action and clinical results in the locoregional treatment of patients with skin cancers and superficial metastases]. (2016) (4)
- Hepatic arterial infusion (HAI) compared to systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma: A systematic review and meta-analysis of randomized controlled trials (2007) (4)
- Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study (2021) (4)
- TNF-based limb perfusion for cutaneous melanoma in transit metastases: suggestions for modification of the perfusional schedule. (2003) (4)
- Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile (2022) (4)
- Risk‐reducing medication for primary breast cancer: a network meta‐analysis (2016) (4)
- The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086) (2021) (3)
- Hyperthermic isolated liver perfusion for unresectable liver cancers: pilot study. (2004) (3)
- Peptides in melanoma therapy. (2012) (3)
- The Role of Electrochemotherapy in the Cutaneous and Subcutaneous Metastases From Breast Cancer: Analysis of Predictive Factors to Treatment From an Italian Cohort of Patients (2021) (3)
- Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study (2021) (3)
- Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral Chemotherapy. (2016) (3)
- Hyperthermic Isolated Liver Perfusion for Unresectable Liver Cancers: Pilot Study (2004) (3)
- TNF and Cancer: Friends and/or Foes? (2012) (3)
- Hypoxic antiblastic stop-flow limb perfusion: clinical outcome and pharmacokinetic findings of a novel treatment for in transit melanoma metastases. (2004) (3)
- Cytokines and Immune Response in the Tumor Microenvironment. (2001) (3)
- Tumor Microenvironment: What have we Learned Studying the Immune Response in this Puzzling Battlefield? (2002) (3)
- Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI) (2020) (3)
- Cancer vaccines: pessimism in check. (2004) (3)
- Atypical Lipomatous Tumor (2020) (3)
- Predictors of toxicity for metastatic melanoma patients treated with ipilimumab (2015) (3)
- Patient outcome after complete surgery for retroperitoneal sarcoma. (2013) (3)
- Chapter 34 – Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune Modulation (2013) (3)
- Melanoma – what is new in sentinel node biopsy and locoregional treatments in 2003? Report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003 (2004) (2)
- A Case of “en bloc” Excision of a Chest Wall Leiomyosarcoma and Closure of the Defect with Non-Cross-Linked Collagen Matrix (Egis®) (2016) (2)
- Breast cancer susceptibility: an integrative analysis of genomic data (2018) (2)
- Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment (2019) (2)
- Cancer rejection by the immune system: Forcing the check-points of tumor immune escape (2005) (2)
- Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei (2018) (2)
- Sentinel lymph node biopsy followed by lymph node dissection for early cutaneous melanoma (2013) (2)
- Isolated Vascular Perfusion of Human Colon with Adenocarcinoma (1999) (2)
- Sentinel Node Biopsy in Cutaneous Melanoma Patients: Technical and Clinical Aspects (2000) (2)
- Fetal Rhabdomyoma (2020) (2)
- [Adjuvant chemotherapy after radical liver resection in the treatment of metastases from colorectal carcinoma]. (2009) (2)
- Use of laser scanning cytometry to study tumor microenvironment. (2003) (2)
- Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective (2022) (2)
- Well-Differentiated (2020) (2)
- Impact of Wide Local Excision on Melanoma Patient Survival: A Population-Based Study (2022) (2)
- The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086) (2022) (2)
- Quality management of cutaneous melanoma: impact on short-term outcomes and costs (2021) (2)
- Hypoxic Antiblastic Stop-Flow Perfusion: Clinical Outcome and Pharmacokinetic Findings (2004) (2)
- Low-Grade Myofibroblastic Sarcoma (2020) (1)
- Cutaneous Angiofibroma (2020) (1)
- Malignant Melanoma: Direct Costs by Clinical and Pathological Profile (2022) (1)
- Extraskeletal Myxoid Chondrosarcoma (2020) (1)
- RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study (2021) (1)
- Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study (2021) (1)
- Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours (2018) (1)
- 126 POSTER The ratio between metastatic and examined lymph nodes (N-ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1,853 patients (2006) (1)
- Granular Cell Tumor (2020) (1)
- Small datasets to develop and validate prognostic models may be a necessary evil to study rare tumours. (2016) (1)
- The Use of Algorithms with a Novel Score Standardization Method for the Selection of Candidate Immunogenic HLA-Specific Peptides Led to the Identification of New Immunogenic HLA-A*0201 Cytomegalovirus Epitopes. (2004) (1)
- Hybrid Nerve Sheath Tumor (2020) (1)
- Anastomosing Hemangioma (2020) (1)
- Editorial: cancer chemoresistance and DNA repair. (2012) (1)
- Epithelioid Fibrous Histiocytoma (2020) (1)
- Interventions for cutaneous sarcoidosis (2013) (1)
- Angioleiomyoma (2020) (1)
- Calcifying Fibrous Tumor (2020) (1)
- Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy (2004) (1)
- First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults (2016) (1)
- Extrarenal Rhabdoid Tumor (2020) (1)
- Myopericytoma (2020) (1)
- IL-10 and systemic lupus erythematosus (2006) (1)
- Cherry Hemangioma (2020) (1)
- Tufted Hemangioma (2020) (1)
- Atypical Vascular Lesion (2020) (1)
- Pleomorphic Dermal Sarcoma (2020) (1)
- Adult Rhabdomyoma (2020) (1)
- The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates (2020) (1)
- Congenital Hemangioma (2020) (1)
- Angiofibroma (2020) (1)
- Induction of endothelial nitric oxide synthase expression by melanoma cells sensitizes tumor endothelium to TNF-driven apoptosis. (2004) (1)
- Tumor immunology. (2007) (1)
- Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility (2021) (1)
- In women with non‐metastatic breast cancer, what are the effects of cognitive behavioral therapy? (2016) (0)
- Cardiac Rhabdomyoma (2020) (0)
- For people with advanced gastric and esophago-gastric junction adenocarcinoma receiving second-line chemotherapy, what are the effects of adjunct biological therapy? (2021) (0)
- Genital Rhabdomyoma (2020) (0)
- In women with metastatic breast cancer, how does high dose chemotherapy and autologous bone marrow or stem cell transplantation compare with conventional chemotherapy at improving outcomes? (2015) (0)
- Fibrous Histiocytoma (2020) (0)
- 45 ORAL “N-ratio” as a novel prognostic factor for patients with stage III cutaneous melanoma (2006) (0)
- The number of excised lymph nodes as quality assurance measure for lymph node dissection in melanoma (2012) (0)
- [Trends in colorectal cancer vaccination]. (2005) (0)
- Treatment of Resectable Advanced Gastric Cancer (2012) (0)
- In women with advanced breast cancer, how do toremifene and tamoxifen compare? (2015) (0)
- Cutaneous Fibroepithelial Polyp (2020) (0)
- Corrigendum: Melanoma in Adolescents and Young Adults (AYA): Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study (2021) (0)
- Lung Chondroma (2020) (0)
- Clear Cell Sarcoma (2020) (0)
- Kidney Soft Tissue Tumors (2020) (0)
- Hepatic Hemangioma (2020) (0)
- Pleomorphic Rhabdomyosarcoma (2020) (0)
- Plexiform Fibrohistiocytic Tumor (2020) (0)
- Adult Fibrosarcoma (2020) (0)
- Pseudomyogenic Hemangioendothelioma (2020) (0)
- Juvenile Hyaline Fibromatosis (2020) (0)
- Elastofibroma (2020) (0)
- In women with uterine cervix carcinoma, how does hyperbaric oxygen added to radiotherapy compare with radiotherapy alone? (2018) (0)
- Dermatofibrosarcoma Protuberans (2020) (0)
- Pseudoangiomatous Stromal Hyperplasia (2020) (0)
- Mediastinum Soft Tissue Tumors (2020) (0)
- Endometrial metastatic neoplasia: Prognostic factors. (2011) (0)
- SMARC-Deficient Thoracic Sarcoma (2020) (0)
- Myolipoma of Soft Tissue (2020) (0)
- Myxofibrosarcoma (2020) (0)
- How does hypofractionation compare with conventional fractionation radiotherapy for men with clinically localized prostate cancer? (2019) (0)
- Low-Grade Fibromyxoid Sarcoma (2020) (0)
- In women with early poor prognosis breast cancer, how does high‐dose chemotherapy plus autologous bone marrow or stem cell transplantation compare with conventional chemotherapy? (2016) (0)
- Disseminated Peritoneal Leiomyomatosis (2020) (0)
- Increased TIA-1 gene expression in the tumor microenvironment after locoregional administration of TNF to patients with limb soft tissue sarcoma. (2003) (0)
- What are the benefits and harms of antifungal drugs for people with neutropenia due to chemotherapy for cancer (2017) (0)
- Digestive System Soft Tissue Tumors (2020) (0)
- Hobnail Hemangioma (2020) (0)
- Hemangioblastoma (2020) (0)
- Glomeruloid Hemangioma (2020) (0)
- Machine learning to predict overall short-term mortality in cutaneous melanoma (2023) (0)
- TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions (2022) (0)
- Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis (2018) (0)
- Basal cell carcinoma: 10-year experience with electrochemotherapy (2017) (0)
- Sex-related difference in the risk of second primary cancers among cutaneous malignant melanoma survivors (2023) (0)
- Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment (2019) (0)
- Analysis of melanoma-related cost factors based on clinical and pathological features (2023) (0)
- Plain language summaries in Simplified Chinese (2016) (0)
- Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis (2013) (0)
- Epidemiology, quality of care, and costs of a soft tissue sarcoma cohort: results from a high-resolution regional registry (2023) (0)
- Cutaneous Melanoma and Hormones: Focus on Sex Differences and the Testis (2022) (0)
- E2F1 germline copy number variations and melanoma susceptibility (2019) (0)
- Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility (2021) (0)
- Uncommon presentation of a giant psoas muscle lipoma: a case report and brief literature review (2023) (0)
- Tumor cellularity beyond the visible in soft tissue sarcomas: Results of an ADC-based, single center, and preliminary radiomics study (2022) (0)
- The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates (2021) (0)
- A systematic literature review of diagnostic and treatment approaches of retroperitoneal lipoma (2023) (0)
- Plain language summaries (2016) (0)
- New paradigm for stage III melanoma: from surgery to adjuvant treatment (2019) (0)
- Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features (2022) (0)
- Bleomycin-based electrochemotherapy for the treatment of a Buschke-Löwenstein tumor (perianal giant condyloma) in an HIV-positive kidney transplant recipient: A case report (2022) (0)
- Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study (2022) (0)
- Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot Study (2022) (0)
- miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis (2019) (0)
- Localized Tenosynovial Giant Cell Tumor (2020) (0)
- Can the levonorgestrel intrauterine system improve outcomes in women taking adjuvant tamoxifen for breast cancer? (2018) (0)
- Pleomorphic Lipoma (2020) (0)
- Hemangioendothelioma (2020) (0)
- Neurothekeoma (2020) (0)
- Dermal Nerve Sheath Myxoma (2020) (0)
- Can adding plerixafor to granulocyte colony-stimulating factor (G-CSF) improve outcomes in people undergoing autologous transplantation for multiple myeloma or non-Hodgkin lymphoma? (2018) (0)
- Lipoma (2020) (0)
- Acral Fibromyxoma (2020) (0)
- Diffuse Tenosynovial Giant Cell Tumor (2020) (0)
- Can altering the sequencing of anthracyclines and taxanes affect outcomes in women receiving adjuvant therapy for early breast cancer? (2019) (0)
- Intimal Sarcoma (2020) (0)
- Identification of patients who most benefit from hepatic arterial infusion (HAI) combined or not with systemic chemotherapy for the treatment of unresectable colorectal liver metastases (2007) (0)
- Pleomorphic Fibroma (2020) (0)
- Rhabdoid Tumor (2020) (0)
- 1 Sentinel node biopsy: the role as a prognostic marker. Preliminary results of the Italian study (2004) (0)
- Lipomatosis of Nerve (2020) (0)
- In women with metastatic breast cancer, how does combination compare with sequential single agent chemotherapy for improving outcomes? (2016) (0)
- Is there randomized controlled trial evidence to support the use of postoperative adjuvant chemotherapy in people with rectal cancer operated for cure (2016) (0)
- Papillary Intralymphatic Angioendothelioma (2020) (0)
- Endometrial Stromal Sarcoma (2020) (0)
- Melanotic Schwannoma (2020) (0)
- Molecular Markers of Lymph Node Disease in Melanoma (2012) (0)
- Acquired Digital Fibrokeratoma (2020) (0)
- A global systematic review of the clinical effectiveness of interventions for cutaneous sarcoidosis: putting the patients first (2012) (0)
- Fibromatosis (2020) (0)
- Extraskeletal Ewing Sarcoma (2020) (0)
- Breast Soft Tissue Tumors (2020) (0)
- Angiolipoma (2020) (0)
- Retiform Hemangioendothelioma (2020) (0)
- Phosphaturic Mesenchymal Tumor (2020) (0)
- Reply to False‐positivity in the sentinel lymph nodes in melanoma and breast cancer (2010) (0)
- Ewing-Like Sarcomas (2020) (0)
- Ovarian Fibroma (2020) (0)
- Definition (2020) (0)
- Can single-dose intravesical chemotherapy after nephroureterectomy improve outcomes in people with upper tract urothelial carcinoma? (2019) (0)
- In people with newly diagnosed leukemia, what are the effects of idarubicin compared with other anthracyclines? (2016) (0)
- Expression in Response to Vaccination Short-Term Kinetics of Tumor Antigen (2001) (0)
- Malignant Granular Cell Tumor (2020) (0)
- Pyogenic Granuloma (2020) (0)
- Inclusion Body Fibromatosis (2020) (0)
- For children with cancer who develop low-risk febrile neutropenia, how does outpatient treatment compare with inpatient treatment? (2019) (0)
- How does post consolidation retinoic acid affect outcomes in patients with high‐risk neuroblastoma treated with autologous hematopoietic stem cell transplantation? (2017) (0)
- Hypoxic antiblastic stop-flow limb perfusion: a novel treatment for in transit melanoma metastases. Clinical outcome and pharmacokinetic findings (2004) (0)
- Myxoid/Round Cell Liposarcoma (2020) (0)
- How does screening with mammography for breast cancer affect mortality and morbidity (2017) (0)
- Extraskeletal Osteosarcoma (2020) (0)
- Fibrous Hamartoma of Infancy (2020) (0)
- Atypical Fibrous Histiocytoma (2020) (0)
- What are the effects of antiangiogenic therapy for people with high-grade glioma? (2018) (0)
- Kidney Rhabdoid Tumor (2020) (0)
- Superficial Fibromatosis (2020) (0)
- Angiomyofibroblastoma (2020) (0)
- Leiomyoma of Deep Tissue (2020) (0)
- Ovarian Sclerosing Stromal Tumor (2020) (0)
- Myxoma (2020) (0)
- Metabolic immune restraints: implications for anticancer vaccines. (2010) (0)
- What are the effects of bisphosphonates in women with early breast cancer (2018) (0)
- Myofibroblastoma (2020) (0)
- The Prognostic Role of Lymph Node Ratio in Patients with Melanoma Lymph Node Metastasis (2013) (0)
- Extraskeletal Chondroma (2020) (0)
- The role of sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy (2015) (0)
- Benign Metastasizing Leiomyoma (2020) (0)
- Spindle Cell Lipoma (2020) (0)
- Liposarcoma (2020) (0)
- In patients having gastrointestinal surgery, what are the benefits and harms of early enteral nutrition versus later commencement of feeding for preventing postoperative complications? (2019) (0)
- Is there randomized controlled trial evidence to support the use of preoperative chemotherapy in people with resectable thoracic esophageal cancer (2016) (0)
- Cardiac Myxoma (2020) (0)
- Breast Phyllodes Tumor (2020) (0)
- Giant Cell Tumor (2020) (0)
- Esophageal Leiomyoma (2020) (0)
- Intermittent versus continuous systemic therapy as treatment for unresectable metastatic colorectal cancer (2016) (0)
- How do erythropoiesis‐stimulating agents affect outcomes in people with cancer? (2016) (0)
- Perineurioma (2020) (0)
- Diffuse Pulmonary Lymphangiomatosis (2020) (0)
- Gastrointestinal Soft Tissue Tumors (2020) (0)
- Myoepithelioma (2020) (0)
- Hepatic Angiosarcoma (2020) (0)
- What are the benefits and harms of tumor bed boost radiotherapy for women with breast cancer who have undergone breast‐conserving surgery? (2018) (0)
- Is there randomized controlled trial evidence to support the use of chemotherapy in people with advanced gastric cancer (2014) (0)
- Cutaneous Epithelioid Angiomatous Nodule (2020) (0)
- Juxtaglomerular Cell Tumor (2020) (0)
- Chondroid Lipoma (2020) (0)
- Inflammatory Fibroid Polyp (2020) (0)
- Rhabdomyosarcoma (2020) (0)
- Uterine Leiomyoma (2020) (0)
- Prostate Stromal Tumor of Uncertain Malignant Potential (2020) (0)
- Cellular Fibrous Histiocytoma (2020) (0)
- Lipofibromatosis (2020) (0)
- How do low-molecular-weight heparin (LMWH), vitamin K agonists (VKAs), and direct oral anticoagulants (DOACs) compare for treatment of venous thromboembolism (VTE) in people with cancer? (2019) (0)
- How does post‐operative radiotherapy affect outcomes in women with ductal carcinoma in situ of the breast? (2016) (0)
- In women with ductal carcinoma in situ, what are the effects of postoperative tamoxifen? (2015) (0)
- New generation cancer vaccines: from tumor immunology to clinical applications. (2010) (0)
- Leiomyosarcoma (2020) (0)
- In severely immunodepressed people, how does fluconazole compare with nystatin for improving outcomes? (2017) (0)
- Mesenchymoma (2020) (0)
- Chest wall control after electrochemotherapy in elderly patients with locoregional recurrence from breast cancer after mastectomy (2013) (0)
- SMARC-Deficient Uterine Sarcoma (2020) (0)
- Synovial Sarcoma (2020) (0)
- Phase II study of neoadjuvant gemcitabine (GC), pegylated liposomal doxorubicin (DX) and docetaxel (TT) in locally advanced breast cancer (2008) (0)
- Angiosarcoma (2020) (0)
- Gastrointestinal Clear Cell Sarcoma (2020) (0)
- In chemotherapy-naive people with advanced non-small cell lung cancer, what are the effects of adding cetuximab to chemotherapy? (2015) (0)
- Forequarter amputation for local recurrence of sarcoma after previous amputation through the shoulder in a female patient – A case report (2021) (0)
- Neurofibroma (2020) (0)
- Epithelioid Sarcoma (2020) (0)
- Uterine Soft Tissue Tumors (2020) (0)
- Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings. (2004) (0)
- How do immune checkpoint inhibitors (ICIs) compare with platinum-based chemotherapy for people with advanced non-small cell lung cancer (NSCLC)? (2021) (0)
- Myxoinflammatory Fibroblastic Sarcoma (2020) (0)
- How does indocyanine green angiography (ICGA) compare with clinical evaluation for women undergoing immediate breast reconstruction following skin-sparing mastectomy? (2020) (0)
- How does early palliative care compare with standard oncological care in adults with advanced cancer (2017) (0)
- Hepatic Embryonal Sarcoma (2020) (0)
- What are the effects of fulvestrant in women with hormone‐sensitive locally advanced or metastatic breast cancer? (2017) (0)
- Biomarkers (2020) (0)
- How do different adjuvant radiotherapy and/or chemotherapy regimens compare in women who have received surgery for uterine carcinosarcoma? (2019) (0)
- EBV-Associated Smooth Muscle Tumor (2020) (0)
- Pleomorphic Liposarcoma (2020) (0)
- Interventions for cutaneous sarcoidosis (Protocol) (2013) (0)
- Skin Soft Tissue Tumors (2020) (0)
- What are the benefits and harms of PARP inhibitors in women with ovarian cancer (2016) (0)
- Can altering the sequencing of anthracyclines and taxanes affect outcomes in women receiving neoadjuvant therapy for early breast cancer? (2019) (0)
- Lung Soft Tissue Tumors (2020) (0)
- Prognosis (2020) (0)
- In women with early breast cancer, how do different types of follow‐up strategy compare with each other for improving outcomes? (2016) (0)
- Acoustic Neuroma (2020) (0)
- Dedifferentiated Liposarcoma (2020) (0)
- Prostate Soft Tissue Tumors (2020) (0)
- How does low-molecular-weight heparin (LMWH) compare with unfractionated heparin (UFH) or fondaparinux for perioperative thromboprophylaxis in people with cancer? (2018) (0)
- Lipomatosis (2020) (0)
- Ectomesenchymoma (2020) (0)
- Extraskeletal Aneurysmal Bone Cyst (2020) (0)
- Pulmonary Myxoid Sarcoma (2020) (0)
- Hepatic Epithelioid Hemangioendothelioma (2020) (0)
- Malignant Triton Tumor (2020) (0)
- Multivariate analysis of SOLISM study: preliminary results (2004) (0)
- Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study (2021) (0)
- Lipofibromatosis-Like Neural Tumor (2020) (0)
- Intramuscular Myxoma (2020) (0)
- The number of excised lymph nodes(LNs) at radical lymph node dissection (RLND) affects survival of patients with melanoma (2012) (0)
- For men with prostate cancer and bone metastases, how do bisphosphonates compare with each other and with denosumab? (2021) (0)
- Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis. (2017) (0)
- Hepatic Mesenchymal Hamartoma (2020) (0)
- Microvenular Hemangioma (2020) (0)
- Pathology (1938) (0)
- In people with advanced non-small cell lung cancer, is there randomized controlled trial evidence to support the use of cisplatin instead of carboplatin in combination with third-generation drugs? (2019) (0)
- Synovial Hemangioma (2020) (0)
- Calcifying Aponeurotic Fibroma (2020) (0)
- Littoral Cell Angioma (2020) (0)
- Cytokines as anti-cancer agents rational, results and perspectives. (2010) (0)
- Fibro-Osseous Pseudotumor of Digits (2020) (0)
- Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) (2020) (0)
- Nasopharyngeal Angiofibroma (2020) (0)
- What are the benefits and harms of adding anti‐gram‐positive antibiotics to standard antibiotics for people with cancer and febrile neutropenia? (2017) (0)
- Epithelioid Hemangioendothelioma (2020) (0)
- How does partial breast irradiation (PBI) compare with whole breast radiotherapy (WBRT) for women with early breast cancer? (2021) (0)
- Uterine Undifferentiated Sarcoma (2020) (0)
- Anastomosis to stomach versus anastomosis to jejunum for reconstructing the pancreatic stump after pancreatoduodenectomy (2016) (0)
- In women with early stage endometrial cancer, how does laparoscopy compare with laparotomy at improving outcomes? (2016) (0)
- Fibrosarcoma (2020) (0)
- Perivascular Epithelioid Cell Tumor (PEComa) (2020) (0)
- Angiomatoid Fibrous Histiocytoma (2020) (0)
- Intraperitoneal chemotherapy in pretreated ovarian cancer patients matched with patients treated with parenteral chemotherapy. (2016) (0)
- Uterine Adenosarcoma (2020) (0)
- Clear Cell Sugar Tumor (2020) (0)
- Myelolipoma (2020) (0)
- How does adjuvant therapy affect outcomes in adult women who have undergone surgery for advanced endometrial cancer (2017) (0)
- Hyperthermic Isolated Perfusion with Low-Dose TNFα and Doxorubicin in Patients with Locally Advanced Soft Tissue Limb Sarcomas. (2004) (0)
- Pleomorphic Hyalinizing Angiectatic Tumor (2020) (0)
- Infantile Fibrosarcoma (2020) (0)
- The Surgical Treatment of Non-Metastatic Melanoma in a Multicenter Registry: A Retrospective Cohort Quality Improvement Study to Reduce the Morbidity Rates (2020) (0)
- Breast Angiosarcoma (2020) (0)
- What are the effects of adjunct all-trans retinoic acid (ATRA) for adults with acute myeloid leukemia (AML)? (2019) (0)
- Sclerotic Fibroma (2020) (0)
- Interleukin-10 and adaptive immune response (2006) (0)
- Multimodal Treatment for Peritoneal Carcinomatosis of Digestive Origin (2002) (0)
- Interventions for congenital ichthyosis (2017) (0)
- SMARC-Deficient Sarcomas (2020) (0)
- How does partial breast irradiation compare with whole breast radiotherapy in women with early breast cancer (2018) (0)
- The challenge of implementing high-throughput technologies in clinical trials. (2005) (0)
- In women undergoing mastectomy alone or mastectomy plus axillary surgery, does fibrin glue instillation under skin flaps prevent seroma-related morbidity? (2015) (0)
- How do chemotherapy regimens that contain taxane compare with those that do not in women with metastatic breast cancer (2015) (0)
- Corrigendum to “Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)” [Eur J Canc 137 (2020). Pages 30–39] (2020) (0)
- Case Report: Surgical Reconstruction of a Massive Thoracic Wall Defect After the Resection of an Undifferentiated Radiation-Induced Sarcoma of the Breast (2021) (0)
- Ectopic Hamartomatous Thymoma (2020) (0)
- Sclerosing Epithelioid Fibrosarcoma (2020) (0)
- Hepatic Calcifying Nested Stromal Epithelial Tumor (2020) (0)
- Desmoplastic Small Round Cell Tumor (2020) (0)
- Tenosynovial Giant Cell Tumor (2020) (0)
- Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade (2018) (0)
- For women undergoing surgery for advanced ovarian epithelial cancer, what are the effects of preoperative chemotherapy? (2021) (0)
- Solitary Circumscribed Neuroma (2020) (0)
- Spleen Soft Tissue Tumors (2020) (0)
- Dermatomyofibroma (2020) (0)
- Uterine Sarcomas (2020) (0)
- Atypical Fibroxanthoma (2020) (0)
- Angiofibroma of Soft Tissue (2020) (0)
- Desmoid Fibromatosis of the Abdominal Wall: Surgical Resection and Reconstruction with Biological Matrix Egis® (2017) (0)
- Bladder Soft Tissue Tumors (2020) (0)
- Epidemiology and Presentation (2020) (0)
- What are the effects of lymphadenectomy in women with endometrial cancer (2017) (0)
- Correlates of toxicity in metastatic melanoma patients treated with ipilimumab. (2016) (0)
- Proliferative Myositis (2020) (0)
- Angiokeratoma (2020) (0)
- Plexiform Fibromyxoma (2020) (0)
- For adults with cancer who develop low-risk febrile neutropenia, how does outpatient treatment compare with inpatient treatment? (2019) (0)
- Cutaneous Angiosarcoma (2020) (0)
- In people with neutropenia or neutrophil dysfunction, can granulocyte transfusions prevent infection? (2016) (0)
- Biphenotypic Sinonasal Sarcoma (2020) (0)
- Cellular Angiofibroma (2020) (0)
- A Dedicated Checklist to Improve the Quality of Reporting in Electrochemotherapy and Enable Comparisons with Other Skin-directed Therapies. (2019) (0)
- In people with locally advanced pancreatic cancer, is there randomized controlled trial evidence to support the use of resection instead of palliative treatment? (2016) (0)
- Arteriovenous Malformation Hemangioma (2020) (0)
- For people with advanced non-small cell lung cancer, how does carboplatin-based chemotherapy compare with cisplatin-based chemotherapy? (2020) (0)
- Schwannoma (2020) (0)
- Undifferentiated/Unclassified Sarcomas (2020) (0)
- [Ovarian carcinoma: pilot study of hyperthermic intraoperative peritoneal perfusion of antiblastic agents]. (1999) (0)
- Infantile Hemangioma (2020) (0)
- Neuroma (2020) (0)
- Leiomyoma (2020) (0)
- How does immediate administration of bisphosphonates compare with delayed administration for women with early‐stage breast cancer? (2018) (0)
- Proliferative Fasciitis (2020) (0)
- Uterine Leiomyosarcoma (2020) (0)
- Ossifying Fibromyxoid Tumor (2020) (0)
- How does surgery compare with tamoxifen in elderly women (70 years plus) with operable primary breast cancer (2016) (0)
- In people with head and neck tumors, how does hyperbaric oxygen added to radiotherapy compare with radiotherapy alone? (2018) (0)
- In women with metastatic breast cancer, what are the benefits and harms of psychological interventions? (2015) (0)
- Malignant Fibrous Histiocytoma (2020) (0)
- Congenital Mesoblastic Nephroma (2020) (0)
- Angiomyolipoma (2020) (0)
- Is there randomized controlled trial evidence to support the use of image guided surgery for the resection of brain tumors (2016) (0)
- Alveolar Rhabdomyosarcoma (2020) (0)
- Undifferentiated Pleomorphic Sarcoma (2020) (0)
- For people treated for non-metastatic colorectal cancer, how do different intensities of follow-up compare? (2020) (0)
- BCOR-Rearranged Sarcoma (2020) (0)
- Epithelioid Hemangioma (2020) (0)
- Cutaneous Leiomyoma (2019) (0)
- Myofibroma (2020) (0)
- In people with anal fissure, how do medical therapies perform and compare with each other for improving outcomes? (2016) (0)
- Erratum: TNF-based limb perfusion for cutaneous melanoma in transit metastases: Suggestions for modification of the perfusional schedule (Journal of Experimental and Clinical Cancer Research (2003) 22, 4 (103)) (2006) (0)
- Solitary Fibrous Tumor (2020) (0)
- Embryonal Rhabdomyosarcoma (2020) (0)
- Aneurysmal Fibrous Histiocytoma (2020) (0)
- Extraskeletal Chordoma (2020) (0)
- Hemangioma (2020) (0)
- How does percutaneous endoscopic gastrostomy compare with nasogastric tube feeding in people with swallowing disturbances (2016) (0)
- Editorial: [Cytokines as Anti-Cancer Agents Rational, Results and Perspectives (Guest Editor: S. Mocellin)] (2010) (0)
- What are the benefits and harms of retinoids for preventing the progression of cervical intra‐epithelial neoplasia? (2017) (0)
- 124. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis – A single institution experience (2012) (0)
- How do laser ablation and conization compare with each other or alternative surgical techniques in women with cervical intraepithelial neoplasia (2016) (0)
- Cutaneous Leiomyosarcoma (2020) (0)
- Desmoplastic Fibroblastoma (2020) (0)
- What are the benefits and harms of radiotherapy after surgery for non‐small cell lung cancer? (2017) (0)
- Angiomatosis (2020) (0)
- Primitive Myxoid Mesenchymal Tumor of Infancy (2020) (0)
- In patients having colorectal surgery, what are the benefits and harms of early enteral nutrition compared with later commencement of feeding for preventing postoperative complications? (2014) (0)
- Nasal Glial Heterotopia (2020) (0)
- What are the effects of preoperative chemotherapy in women undergoing surgery for advanced ovarian epithelial cancer? (0)
- What are the benefits and harms of chemotherapy in children with medulloblastoma (2016) (0)
- Is there randomized controlled trial evidence to support the use of chemotherapy alone instead of endocrine therapy alone in women with metastatic breast cancer (2015) (0)
- Pleuropulmonary Blastoma (2020) (0)
- What is the accuracy of magnetic resonance imaging (MRI) and systematic biopsy for detection of grade 2 or higher prostate cancer? (2020) (0)
- Kidney Clear Cell Sarcoma (2020) (0)
- Giant Cell Fibroblastoma (2020) (0)
- How does pembrolizumab compare with chemotherapy for people with advanced urothelial carcinoma that progressed during or after platinum-containing chemotherapy? (2018) (0)
- Tu1225 - Postoperative Fever of Unknown Origin is Associated to Lymphopenia after Esophagectomy for Cancer (2018) (0)
- Alveolar Soft Part Sarcoma (2020) (0)
- (Anticancer Research 30, 9, (3817)) (2011) (0)
- Myositis Ossificans (2020) (0)
- Fibroma of Tendon Sheath (2020) (0)
- Lipoblastoma (2020) (0)
- High-Grade Endometrial Stromal Sarcoma (2020) (0)
- Hibernoma (2020) (0)
- How does early compare with deferred standard androgen suppression therapy (AST) for men with advanced hormone-sensitive prostate cancer? (2019) (0)
- Inflammatory Myofibroblastic Tumor (2020) (0)
- How does flumazenil compare with placebo in people with cirrhosis and hepatic encephalopathy (2017) (0)
- In women with breast cancer, can primary prophylactic colony-stimulating factors help prevent chemotherapy-induced febrile neutropenia? (2016) (0)
- What are the effects of pre-operative chemotherapy in women undergoing surgery for advanced ovarian epithelial cancer? (2019) (0)
- How does glue compare with suture for mesh fixation in patients undergoing Lichtenstein inguinal hernioplasty (2017) (0)
- Intramuscular Hemangioma (2020) (0)
- Spindle Cell Hemangioma (2020) (0)
- Malignant Peripheral Nerve Sheath Tumor (2020) (0)
- Kaposi Sarcoma (2020) (0)
- Etiology and Predisposition (2020) (0)
- Cardiac Soft Tissue Tumors (2020) (0)
- Prostate Stromal Sarcoma (2020) (0)
- Mesenchymal Chondrosarcoma (2020) (0)
- Peripheral Primitive Neuroectodermal Tumor (2020) (0)
- Do conservative interventions help to prevent lymphedema after breast cancer therapy (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Simone Mocellin?
Simone Mocellin is affiliated with the following schools:
